NVCR Novocure Ltd

USD 16.50 0.00 ( 0.00%)
Icon

Novocure Ltd (NVCR) Financial Statements

COMMON STOCK | Medical Devices | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 16.50

0.00 (0.00%)

USD 1.81B

0.65M

USD 33.83(+105.05%)

N/A

Icon

NVCR

Novocure Ltd (USD)
COMMON STOCK | NSD
USD 16.50
0.00 ( 0.00%)

Novocure Ltd (NVCR) Annual Income Statement (USD)

NVCR Quarterly Financials (USD)

Frequently Asked Questions About Novocure Ltd (NVCR) Stock

Novocure Ltd's (NVCR) last reported annual revenue was USD 605.22 Million.

Novocure Ltd's (NVCR) annual revenue growth rate based on the revenue reported in the past 5 years is : 11.49%

Novocure Ltd's(NVCR) is not profitable as of its last reported annual financials.

The net profit margin for Novocure Ltd's(NVCR) from its laster reported year is -27.86%

The return on equity (ROE) for Novocure Ltd's(NVCR) from its last reported annual financials is : -46.67%

The return on assets (ROA) for Novocure Ltd's(NVCR) from its last reported annual financials is : -8.77%

The return on invested capital (ROIC) for Novocure Ltd's(NVCR) from its last reported annual financials is : -21.36%

The Debt to Equity ratio for Novocure Ltd's(NVCR) from its last reported annual financials is : 27.01%

The dividend yield for Novocure Ltd's(NVCR) from its laster reported year is 0.00%

Novocure Ltd's(NVCR) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...